Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Sarah A. Small"'
Autor:
Kara Chandler, Josh Millar, George Ward, Christopher Boyall, Tom White, Joseph David Ready, Rawan Maani, Keith Chapple, Robert Tempest, Joseph Brealey, Catherine Duckett, Sarah Haywood-Small, Simon Turega, Nick Peake
Publikováno v:
Cells, Vol 13, Iss 1, p 24 (2023)
Extracellular vesicles (EVs) are lipid bilayer structures released by all cells that mediate cell-to-cell communication via the transfer of bioactive cargo. Because of the natural origin of EVs, their efficient uptake by recipient cells, capacity to
Externí odkaz:
https://doaj.org/article/01b7d8de889a4170848fe6f1a65090dd
Autor:
Sarah F Small
Publikováno v:
Maine Policy Review, Vol 31, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/f1068923c06d473d8e0885dc72950b81
Autor:
Ranwa A. Elrayess, Mahmoud E. Mohallal, Yomn M. Mobarak, Hala M. Ebaid, Sarah Haywood-Small, Keith Miller, Peter N. Strong, Mohamed A. Abdel-Rahman
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
Within the last decade, several peptides have been identified according to their ability to inhibit the growth of microbial pathogens. These antimicrobial peptides (AMPs) are a part of the innate immune system of all living organisms. Many studies on
Externí odkaz:
https://doaj.org/article/3595085573d74a9fbbea191f80f487e1
Autor:
Cristina Russo, Cameron Heaton, Lucy Flint, Oana Voloaca, Sarah Haywood-Small, Malcolm Ronald Clench, Simona Francese, Laura Margaret Cole
Publikováno v:
Journal of Spectral Imaging, Vol 9, Iss 1, p a13 (2020)
Mass spectrometry imaging (MSI) is a powerful and versatile technique able to investigate the spatial distribution of multiple non-labelled endogenous and exogenous analytes simultaneously, within a wide range of samples. Over the last two decades, M
Externí odkaz:
https://doaj.org/article/69239562e3cc4a8ab59507a5789d9dc0
FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue
Autor:
Kathleen R. Markan, Meghan C. Naber, Sarah M. Small, Lila Peltekian, Rachel L. Kessler, Matthew J. Potthoff
Publikováno v:
Molecular Metabolism, Vol 6, Iss 6, Pp 602-610 (2017)
Objective: Fibroblast growth factor 21 (FGF21) is an endocrine hormone that regulates metabolic homeostasis. Previous work has suggested that impairment of FGF21 signaling in adipose tissue may occur through downregulation of the obligate FGF21 co-re
Externí odkaz:
https://doaj.org/article/38d9394ad9fb4cf9b60cc49fb5a21224
Autor:
Sarah F. Small
Publikováno v:
Eastern Economic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c634b8f289a3820adccbd023bdf9709d
https://doi.org/10.1057/s41302-023-00238-1
https://doi.org/10.1057/s41302-023-00238-1
Autor:
Sarah F. Small
Publikováno v:
Erasmus Journal for Philosophy and Economics. 15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b4b3a36b50f69fd4a3fa5d6c34a9d4b
https://doi.org/10.23941/ejpe.v15i2.668
https://doi.org/10.23941/ejpe.v15i2.668
Publikováno v:
Health Psychology Open, Vol 5 (2018)
Fibromyalgia is a severe chronic pain condition that affects every aspect of life. Causes of the condition remain unclear, and quantitative research cannot account for patients’ personal illness narratives and perceptions. This online survey gather
Externí odkaz:
https://doaj.org/article/ba7b5bc8863143e39a564a1b4df4e559
Publikováno v:
Health Psychology Open, Vol 4 (2017)
This study explores the life and treatment experience of people in the United Kingdom with fibromyalgia in order to inform the development of treatments which are both effective and acceptable to users. Qualitative interviews were conducted with 14 p
Externí odkaz:
https://doaj.org/article/065d2b2debc64607a7b9e30ba3b873d0
Autor:
Sean D. Stocker, Corry D. Bondi, Sarah A. Small, Donna B. Stolz, Thomas W. Kensler, Soma Jobbagy, Sheldon I. Bastacky, Dionysios V. Chartoumpekis, Kacie M. Barry, Roderick J. Tan, Jason Ong, Brittney M. Rush
Publikováno v:
Kidney International. 99:102-116
The nuclear factor erythroid 2-related factor 2 (Nrf2) pathway upregulates key cellular defenses. Clinical trials are utilizing pharmacologic Nrf2 inducers such as bardoxolone methyl to treat chronic kidney disease, but Nrf2 activation has been linke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be9af679940310be2dfa0c606293ede2
https://doi.org/10.1016/j.kint.2020.07.036
https://doi.org/10.1016/j.kint.2020.07.036